ABSTRACT: Continuous positive airway pressure devices are routinely used to treat sleep breathing disorders. Automated devices that adjust the therapeutic pressure have recently been proposed. The utility of such devices is still controversial, as rigorous clinical comparisons are difficult to perform as a result of patient and device differences.
Patients with obstructive sleep apnoea syndrome (OSAS) are often chronically treated with continuous positive airway pressure (CPAP), which may induce several side-effects, limiting treatment tolerance and compliance. Auto-adjusting positive airway pressure (APAP) systems have been developed and clinically tested for several years [1] [2] [3] [4] [5] [6] [7] . They are aimed at improving effectiveness and, possibly, reducing side-effects of CPAP by providing optimal pressure, which is found, on average, to be lower than a continuous level [8] . They may improve tolerance by reducing mask pressure (Pm) and, probably, mask leaks. It has been demonstrated that, in patients requiring high pressures, compliance was statistically increased [7] . However, the clinical significance of this observation remains unproven. APAP are also potentially cost-efficient auto-titrating systems [9, 10] . Nevertheless, in some reports, failure of the APAP required manual resetting, whilst, in others, undesirable cardiorespiratory complications have been described [11] [12] [13] [14] .
The principle of these machines is based on two successive steps: 1) the detection of abnormal events; and 2) the reaction against these abnormalities by specific algorithms. These two steps have been achieved by different methods. However, the principle is always to build an interactive device that reacts in a closed loop to the detected upper airway (UA) abnormality. Given the wide variety of algorithms used by these devices [15] [16] [17] [18] , clinical tests do not allow general conclusions to be derived for particular apparatus that are valid in all patients.
In a recent review, BERRY et al. [19] emphasised the fact that no study has compared the technologies of APAP devices that may not give the same results in a given patient. A bench study has been proposed to evaluate the responses of automatic devices to well-defined breathing patterns of sleep apnoea-hypopnoea syndrome (SAHS) patients [20] . In this study, the devices were evaluated in an open loop state, i.e. with a steady imposed perturbation of airflow, which remained unchanged by the automatic response of the APAP. In other words, steady patterns of disturbed breathing, stored in a computer, were applied to APAP devices, which could react by changing pressure. Nevertheless, airflow remained unaffected by these pressure changes, a condition that is unrealistic compared to clinical situations. Indeed, any change in airway pressure is accompanied by a change in UA size. Consequently, airflow pattern is modified. Therefore, this method could only challenge the event detection system, but could not test the pressure-response algorithms of the devices in reaction to secondary change in airflow pattern.
Several studies have shown that the mechanical properties of UA in children and adults with OSAS can be predicted by the behaviour of a collapsible tube described as a Starling resistor [21] [22] [23] [24] . Therefore, this model was used to study the response of APAP devices to mechanical behaviour of the UA.
The current authors aimed to define the detection ability of the APAP and their potential capacity to correct breathing abnormalities during reproducible UA perturbation. Therefore, a model of the respiratory system was proposed, which allowed evaluation of the closed-loop behaviour of the APAP, as a first step in determining the effectiveness of each apparatus in a therapeutic context.
Materials and methods

Sinusoidal pump
A custom-made pump ( fig. 1 ) generated a sinusoidal airflow, at a rate of 12 cycles?min -1 , and a tidal volume (TV) of 1 L. It was connected to a Starling resistor by an extendable tube acting as the trachea.
Starling resistor
The Starling resistor was made from a cylindrical airtight transparent chamber (220 mm long, 90 mm internal diameter) containing a compliant rubber tube, as described by FARRÉ et al. [25] .
The "larynx" was connected to the tracheal tube, whilst the "nose" was connected to the patient circuit ( fig. 1 ). Pm and tracheal pressure (Ptr) were measured (Validyne DP45-16, ¡50 cmH 2 O and DP45-24, ¡50 cmH 2 O; Validyne, Northridge, CA, USA). Ptr was used as an index of the respiratory efforts to indicate the severity of the UA collapse. The chamber pressure (Ptis) was controlled by a CPAP (Somnotron3; Weinmann, Hamburg, Germany) and a continuous negative airway pressure (CNAP), derived from a modified positive pressure device (Remstar; Respironics Inc, Murrysville, PA, USA). The two devices were mounted in parallel, using a T-piece adapted on the sealed box. The box pressure was monitored by a calibrated digital manometer (Respironics Inc). Normal breathing was simulated when the CNAP was powered on. The negative pressure acted as an increase in the UA dilator muscle activity. Partial or total collapse was simulated when the CPAP was powered on. The positive pressure around the collapsible tube acted as a decrease in the UA dilator muscle force.
The rubber tube critical closing pressure was evaluated at the mask by replacing the APAP by the CNAP, to apply negative pressure at the "nose". Ptis was then set at 0 cmH 2 O in the box, and Pm was progressively decreased [24] . A closing pressure of -2.2 cmH 2 O was observed at complete interruption of inspiratory airflow.
Patient circuit
Each APAP system was connected, using its proprietary tube, to a conventional leak port (3 mm diameter) and to a pneumotachometer (Hans Rudolph 4700 Series; Hans Rudolph Inc, Kansas City, MO, USA). The leak port is used to avoid CO 2 rebreathing in patients. Airflow was measured by using a differential transducer (Validyne DP45-16, ¡2 cmH 2 O; Validyne). The pneumotachometer was connected to the Starling resistor using a rigid tube containing a manual tap to simulate "mask" leaks.
Study devices
The study included five APAP systems commonly used for treatment of sleep breathing disorders: GK 418P (Mallinckrodt, Villers Les Nancy, France), Autoset1T (ResMed, North Ryde, Australia), REMstarAuto1 (Respironics), PV10i (Breas Medical, Mö lnlycke, Sweden) and SomnoSmart1 (Weinmann). Lower and upper pressures of the devices were set at 4 and 18 cmH 2 O, respectively, whilst the pressure ramp was disabled. On the GK 418P, the maximum pressure in response to apnoea was set at 13 cmH 2 O. This device was set, initially, to react in the presence of central apnoeas and, secondly, to ignore them. The pressure rate was set on the SomnoSmart1 to 0.4 cmH 2 O?s -1 . The other devices were used in their default setting given by the manufacturers. 
Signal acquisition
Signals were sampled at a frequency of 50 Hz and collected using a 12-bit Analog to Digital converter (MacADIOS II; GW Instruments Inc, Sommerville, MA, USA). Airflow was calibrated using a rotameter and continuous flow source. The TV of each cycle was computed after digital integration of the measured airflow.
Protocol
Different flow patterns ( fig. 2) were generated by the mechanical model. Airflow through the collapsible tube was managed by the relationship between Pm, Ptr and Ptis. Briefly, if PmwPtrwPtis, then the airflow pattern is normally rounded. If PmwPtiswPtr, the model snores and the airflow is flattened. Finally, if PtrvPmvPtis, the airway conduct becomes obstructed [26] .
Normal airflow shape. The pharyngeal tube presented a flat cross-section that collapsed easily and had virtually no crosssectional area at zero transmural pressure. It was then necessary to apply negative pressure inside the box to maintain its open state and, thus, to obtain a rounded airflow shape. A cycle was considered as normal when the TV was o95% of baseline volume.
Hypopnoea. Hypopnoea was defined when 10%vTVv70%. U-shaped and square-shaped repetitive hypopnoeas were generated separately. A flattened inspiratory U-shaped pattern was characterised by two rapid inspiratory flow peaks in the same cycle, and snoring was often present. The first peak was present at the beginning of the inspiration and the second one at the end. To obtain a flattened square shape, a balloon of 3 L (Datex-Ohmeda, Helsinki, Finland) was placed in parallel with the sinusoidal pump. This compliant element was added to damp the inspiratory flow peaks observed with the U-shape and to suppress the snoring noise. Obstructive apnoea. When the tube was obstructed, low negative values were reached by Ptr (-50 cmH 2 O) as a result of the pump movements, which were similar to the efforts observed in human obstructive apnoeas. The TV decreased to values f10% baseline.
Flow limitation. Flow limitation was defined as 70%fTVv95%. As a balloon was used, as explained previously, no snoring was observed on both pressure and flow signals.
Simulated snoring. Snoring resulted from the flutter of the collapsible tube. Snoring was audible and was not associated with significant airflow reduction. The fluttering was visible on the rubber tube at its connection with the larynx. The snoring fundamental frequency was y105 Hz.
Central apnoeas. Repetitive central apnoeas with opened UA were produced whilst the pump was shut down. In the meantime, an oscillation at 1 Hz was applied at the mask, by an external source, to simulate cardiogenic flow oscillations. The external source consisted of a rodent respiratory pump (UGO BASILE, Comerio, Italy). The displaced volume was 0.1 mL and the resultant pressure oscillation was y ¡ 0.5 cmH 2 O.
Mask leaks. APAP systems were submitted to a continuous controlled mask leak of 0.8 L?s -1 in the normal breathing state. Events were manually created at a rate of y70-77?h -1 . Between each experiment, the APAP systems were allowed to return to their minimal pressure value. Thus, each airflow pattern was simulated, whilst the APAP was initially set at 4 cmH 2 O.
The time taken to reach maximal APAP in response to an event was defined as the reaction time (tR). To evaluate the effectiveness of the response, the residual apnoea and hypopnoea indices (AI and HI, respectively) were calculated once the device reached its maximum pressure.
Results
Response to apnoeas Figure 3 shows partial recordings of 15 min when obstructive apnoeas were imposed. The first part of each plot shows the initial 12.5 min of the recording, whereas the second part represents the final pressure reached by the different devices and the corresponding airflow during 2.5 min. The GK 418P, the AutoSet1T, the REMstarAuto1 and the SomnoSmart1 progressively changed apnoeas to hypopnoeas, whereas the PV10i completely suppressed the obstruction. Two devices (AutoSet1T and SomnoSmart1) increased the pressure by large increments, whereas the others increased the pressure more smoothly. The complete recording is summarised in figure 4 and table 1.
Two devices (AutoSet1T and GK 418P) suppressed apnoeas with a relatively short tR, but maintained U-shaped hypopnoeas with a high residual index for the AutoSet1T (HI 55?h -1 ). Whilst the other devices abolished apnoeas and hypopnoeas, they maintained flow-limited cycles. The maximum pressures reached ranged from 11.5 cmH 2 O (AutoSet1T) to 16 cmH 2 O (SomnoSmart1).
Response to hypopnoeas
When simulating hypopnoeas with a U-shape ( fig. 5, table 2 respectively. Consequently, all hypopnoeas were suppressed. The SomnoSmart1 pressure response was unstable, which explains the low residual index (HI 9?h -1 ) despite its high pressure (Pm 8.7 cmH 2 O). tR values were shorter than in the case of obstructive apnoeas (2-6 min). The AutoSet1T, the PV10i and the REMstarAuto1 suppressed all hypopnoeas with a square shape ( fig. 6 ), whereas the GK 418P decreased the index to 27?h -1 . The SomnoSmart1 did not reduce this index below 59. As for tR values, they differed from that of the U-shaped hypopnoeas (1-10 min).
The results presented in table 3 show the differences in residual hypopnoea indices when event classification was based on tidal volume (HITV), maximal inspiratory airflow (HIF1) and the difference between minimal to maximal flow, computed cycle by cycle (HIF2). For all methods, the same limits in percentage were used to identify events as described in the Protocol section. Only the simulated obstructive apnoeas and hypopnoeas were considered. For the squareshaped hypopnoeas and obstructive apnoeas, flow-derived residual indices (HIF1 and HIF2) were higher than volumederived indices (HITV) on the GK 418P. On the REMstarAuto1, HIF1 was higher when considering square-shaped hypopnoeas and obstructive apnoeas.
With the PV10i, residual square-shaped hypopnoeas persisted when computed by HIF2.
Finally, all devices maintained a significant number of flattened cycles (figs 4, 5 and 6).
Response to flow limitation and snoring
Persistent flow limitations were not suppressed, even if some devices (AutoSet1T, SomnoSmart1 and GK 418P) increased the pressure at the first flattened cycles and maintained this level thereafter. In spite of this increased pressure, 100% residual flow-limited cycles were observed.
Simulated snoring was detected and corrected by all devices except the AutoSet1T. The other devices raised the pressure until total elimination of snoring (REMstarAuto1 and GK 418P) or partial blunting of snoring (PV10i and SomnoSmart1).
Response to central apnoeas
All the devices, except the SomnoSmart1, increased the pressure with central apnoeas. The AutoSet1T and the PV10i increased and maintained the pressure at 10 and 11 cmH 2 O, respectively, whereas the REMstarAuto1 increased the pressure to 11 cmH 2 O, before decreasing it to 8 cmH 2 O. The GK 418P was initially programmed not to react on central apnoeas with cardiac oscillations. Nevertheless, the pressure increased to 9.5 cmH 2 O. When the GK 418P was set to react to these events, the pressure further rose to 13 cmH 2 O. 
Response to constant mask leaks
The imposed leak resulted in a Pm drop and airflow drift ( fig. 7) . Consequently, inspiratory airflow became abnormally flat and was associated with high inspiratory efforts (Ptr -30 cmH 2 O), indicating a flow limitation. The device reacted to this event, and the airflow shape normalised again once the Pm returned to pre-leak value. This pattern was observed with three devices (REMstarAuto1, PV10i and SomnoSmart1). Neither the GK 418P nor the AutoSet1T compensated for this mask leak. Therefore, with these last two devices, the airflow pattern remained abnormal.
Relationship between airflow and tracheal pressure
The airflow shape is closely associated with the tracheal pressure. This is illustrated in figure 8 , where an improvement of airflow shape is accompanied by an increase of both airflow amplitude and tidal volume and a reduction of Ptr swings.
Discussion
The main results of this study are as follows. 1) Tested APAPs are able to detect and to overcome obstructive Data are presented as n. Data are presented as n.
apnoeas, but, nevertheless, all devices maintained significant residual hypopnoeas and flow limitations (GK 418P and AutoSet1T), or flow limitations only (RemStarAuto1, PV10i and SomnoSmart1). 2) One device did not fully normalise the hypopnoeas in either shape (GK 418P). The AutoSet1T did not correct the U-shaped hypopnoeas, whereas the SomnoSmart1 did not suppress the squareshaped ones. The other two devices corrected hypopnoeas, but left significant flow limitations. 3) Persistent flow limitation was not modified by any device, despite small pressure increases in three devices (AutoSet1T, SomnoSmart1 and GK 418P). 4) Snoring was suppressed with various tR by all devices, except for the AutoSet1T. 5) Mask leaks of #0.8 L?s -1 were not compensated for in two devices (AutoSet1T and GK 418P), even though the reduction in Pm caused an abnormal airflow. 6) The SomnoSmart1 was the only device to maintain a low pressure at 4 cmH 2 O when central apnoeas were simulated.
As well as UA anatomy, muscle activity plays a great role in the amount of air that can flow through the pharynx. Using the Starling resistor model, the mechanical effect of the UA muscle activity on the pharynx could be taken into account. Thus, allowing the APAP device to react on the model of the UA led to a more realistic approach of the overall functioning of the devices than in a previous bench study [20] . FARRÉ et al. [20] used airflow patterns from recorded patients and submitted APAP devices to these patterns. However, this study did not allow the APAPs to modify the airflow pattern despite their pressure increase, since the abnormal airflow sequences were programmed and imposed. Such a situation is unrealistic, since this open loop model cannot provoke the expected UA modifications that result from the APAP reaction. Only a closed loop method can do this. Thus, the major difference between the two models is that the current authors9 closed loop setup reacted not only to pressure changes imposed around the collapsible tube, i.e. Ptis, but also to those generated by the APAP. This mechanical model simulated the situation of an active patient, whose breathing pattern depended on pressures applied both by the patient9s UA muscles and by the APAP device. Thus, this model is better adapted to induce and evaluate APAP reaction to various patient situations. The airflow progressively changed from an abnormal shape to a normal shape as the APAP pressure increased. By contrast, in the FARRÉ et al. [20] model, obstructive events, such as apnoeas or hypopnoeas, remained imposed even at elevated Pm values, thereby preventing any evaluation of the improvement in flow patterns.
Obstructive events in patients may appear suddenly or be preceded by forerunner signs, such as snoring or flow limitation [27] . APAP devices9 algorithms should probably detect these early signs to prevent total closure of the pharynx and to maintain the airway patency. Higher pressures are therefore required [28] .
The snoring cycles were characterised by flattened shapes of both airflow and Pm, in addition to an increase of the tracheal pressure swings. The fundamental oscillation frequency of snoring, in this model, was in the range of those observed in humans [29] . In a bench study, differences were reported between six commercially available APAP devices in their sensitivity for detecting snoring on a lung model [30] . The authors showed that snoring detection is less sensitive for the AutoSet1T compared with the GK 418P. The complete lack of reaction to snoring of the AutoSet1T in the current authors9 model may be related to the amplitude of the snoring pressure oscillation, which was y0.7 cmH 2 O, whereas in the LOFASO et al. [30] study, it was y1 cmH 2 O.
Flow-limited cycles were characterised by a decrease of TV, associated with large tracheal pressure swings ( fig. 8) . Prolonged flow limitations were not corrected and repetitive flow-limited cycles, separated by normal cycles, were not suppressed. However, response to prolonged flow-limitation events may not be desirable, as they are physiologically observed in stage 3-4 of sleep and they do not lead to repetitive arousals [31] . AITTOKALLIO et al. [32] emphasised the usefulness of advanced signal processing in classifying different airflow shapes. Furthermore, EPSTEIN et al. [33] showed that flattening, detected on a flow signal, provided by a nasal cannula, may be an alternative to invasive oesophageal pressure measurement. Even if a direct effort measurement is not readily available, APAP devices may have sufficient data to perform effective event recognition, by evaluating the severity of the flattening using flow-shape analysis.
In the current study, the criteria used to define hypopnoea and apnoea events are based on precise quantitative measurements of the actual TV of each cycle. The American Academy of Sleep Medicine criterion [34] is a decrease of o50% of baseline amplitude of a valid measurement of breathing during sleep. This method uses only peak-to-peak measurement of airflow, which is much less accurate than actual TV integrated over the total respiratory cycle. The current authors submitted APAPs to two realistic flattened patterns of hypopnoeas, commonly observed on SAHS patients [32] . The AutoSet1T did not suppress the Ushaped flattening and left an HI of 62?h -1 . This result was not expected with this device, since the algorithm is supposed to anticipate total airway closure. The pressure was raised by only 2 cmH 2 O, which suggests that the AutoSet1T device recognised the abnormality, but did not increase the pressure sufficiently. The detection of U-shaped hypopnoeas also failed on the GK 418P, whereas the square shape was partially corrected. The PV10i and the REMstarAuto1 eliminated all types of hypopnoeas, but maintained repetitive flow limitations. The SomnoSmart1 increased the pressure in the flattened cycles and decreased it immediately in the normal ones. This latter device is driven by a simplified forced oscillatory technique, producing a 20 Hz oscillation and measuring an oscillating pressure signal (OPS). The OPS increases in the presence of a partial or total collapse of the UA. The Pm signal was consequently very unstable and fluctuating, resulting in the persistence of some U-shaped hypopnoeas (HI 9). With square-shaped hypopnoeas, the SomnoSmart1 did not increase the pressure w5 cmH 2 O and the HI remained high (HI 59?h -1 ). This low performance was probably due to the low values of OPS in this mode at inspiration compared with expiration. This may have resulted from the damping of the 20 Hz oscillations in the balloon.
All devices overcame obstructive apnoeas. The AutoSet1T and the SomnoSmart1 increased the pressure rapidly, which is not recommended in sleeping patients because of potential arousals [35] .
The most frequently used signal to define events in the sleep laboratories is the airflow, where the peak flow amplitude and the inspiratory flow shape are used to identify events. By choosing the TV [20] , the current authors used a more stringent criterion. To compare these methods, residual events were computed using volume and flow criteria (table 3) . For the GK 418P and the REMstarAuto1, residual indices were higher when using the flow signal. These differences in residual indices are related to the fact that a cycle will be considered as only flow limited by analysing its volume, but it may be classified as a hypopnoea using its flow amplitude. The use of the flow signal instead of the TV may then lead to different residual indices. Thus, differences between APAP devices in reaction to respiratory events may result from different detection strategies. These results suggest that some devices did not suppress flattened cycles, as a result of their criteria for detecting abnormal flow.
However, the commonly used peak flow is not as representative of ventilation as the TV. As shown in figure 2 , the U-shaped flow curve is characterised by a high peak flow at the beginning of the inspiration, whereas a reduction in mean flow amplitude is present during most part of the inspiration. Thus, this peak flow value does not necessarily reflect the severe decrease in amplitude that characterises this shape.
In the case of central apnoeas, pressure should not be increased [2, 36] . Nevertheless, all devices, except for the SomnoSmart1, increased the pressure. The forced oscillatory technique of the SomnoSmart1 showed its sensitivity in differentiating between open and closed UA. The GK 418P monitoring software showed that these events were processed as obstructive or mixed apnoeas causing pressure increases. Only the PV10i and the AutoSet1T algorithms did not separate between obstructive and central apnoeas. These events were classified as apnoea. Even if the two latter devices are not specifically designed to treat central apnoeas, such events may occur in a given patient. In this case, an APAP device should provide a null or moderate pressure increase. The REMstarAuto1 did not identify the central apnoeas with accuracy, but characterised them as nonresponsive events.
The current data show that mask leaks occurring at minimal effective positive pressure cause flow limitation or snoring associated with increased tracheal pressure swings. The hypothesis that APAP units monitoring flow or impedance may systematically fail to titrate properly because of high mask leaks [19] is disproven, as a result of the current data showing an adequate reaction by some devices (SomnoSmart1, PV10i and REMstarAuto1). The confusion between leak periods and apnoea or hypopnoea events [19] should not be possible when a proper flow-signal analysis is performed. A mask leak is systematically accompanied by opposite offsets of mask pressure and airflow signals ( fig. 7) .
The current authors9 model has the advantage of wellcontrolled and stable conditions for APAP studies, so that each experiment is reproducible for each device. Such a comparison study is not possible on humans, as a result of intra-and inter-patient variability. Differences between patients in pharynx anatomy, AI/HI, snoring frequency, sleep quality, mask tolerance and noise susceptibility can be considered as explanatory factors of different outcomes between devices rather than actual device differences.
These results contrast with some positive reports of the clinical efficacy of APAP devices for automated CPAP titration [36, 37] . Reasons for these discrepancies may be related to event classification in other studies that take into account apnoeas and hypopnoeas, but not flow limitations. Another reason could be the clinical efficacy of some devices in snoring detection, which is often a forerunner sign of UA obstruction. Insofar as failures of detection algorithms with several devices have been detected, it is important to validate carefully event reports of APAP and to monitor their performance by independent means.
Limitations of the study
This model does not take into account all mechanisms of UA pathophysiology, such as variations in UA muscle activity within the respiratory cycle, the surface tension changes in UA or all possible airflow patterns. Despite these differences, the critical closing pressure of the model was close to values observed on normal subjects [38] . The current authors have tested only some specific airflow patterns similar to that observed in patients. Furthermore, the airflow waveforms were flattened at the inspiration only. Therefore, the current study could not cover all combinations of inspiratory and expiratory airflow abnormalities.
A mechanical model cannot evaluate directly if simulated hypopnoeas and flow-limited events precipitate desaturation and/or arousals, as these parameters are not built in to the model. However, there is strong indirect evidence that it should be the case in an equivalent clinical setting. Indeed, the high tracheal pressure decrements seen in figure 8 (y40 cmH 2 O), during events labelled "hypopnoeas" and "flow-limited", are known to induce arousals in humans [39] .
Furthermore, it is difficult to estimate actual desaturation from the model, since, besides hypoventilation, many factors are associated with sleep-disordered breathing, including variation in oxygen stores across patients, as well as potential variation in O 2 consumption and CO 2 production under sleep apnoeic/hypopnoeic/flow-limited conditions.
The capabilities of the devices to react against a mechanical model may be questioned when compared to better clinical results. However, elevated residual indices of hypopnoeas or flow limitation during simulated obstructive apnoeas were not related to a pressure limit of the devices, since all the machines did not reach the maximum pressure setting (maximum pressure was 16 cmH 2 O with the SomnoSmart1 and PV10i). This failure may be linked to a built-in limitation of the algorithms, which probably applies to clinical situations as well.
In conclusion, tested auto-adjusting positive airway pressure devices had different responses under the same experimental conditions. These differences are indicated by the amount of pressure increase and reaction time in response to the same event. Whilst all devices adequately detected and treated total upper airway collapse, some devices did not correct hypopnoeas. The detection of flow-limited cycles and differentiation between central and obstructive events needs to be improved in most devices, using accurate tools, such as signal processing. In addition, the current study suggests that it is necessary to visualise the raw data of the device to better evaluate its automatic response. This model of the upper airway is a valuable first step in comparing technological advances in the treatment of sleep apnoea-hypopnoea syndrome patients, but must be supplemented by clinical studies for devices that have proven their efficacy in the bench test.
